Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Public ClinicalTrials.gov record NCT01370733. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate the safety and efficacy of synchronized transcranial magnetic stimulation (sTMS) using the NeoSync EEG Synchronized TMS device (NEST) in subjects with Major Depressive Disorder. This is a multicenter study in which subjects will be randomized to receive treatment 5 days per week for 6 weeks. Subjects who complete 6 weeks of double-blind treatment may be eligible to receive up to four weeks of open label sTMS therapy or antidepressant medications during the follow-up phase of the study. Follow-up evaluation visits will be conducted during those four weeks, with the frequency of the visits determined by the treatment choice during that timeframe.
Study identification
- NCT ID
- NCT01370733
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 202 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2012 (Type not available)
- Primary completion
- Aug 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Oct 26, 2015
2012 – 2013
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Depression Research & Clinic Program | Los Angeles | California | 90024 | — |
| UCSD Medical Center | San Diego | California | 92103 | — |
| UCLA-Harbor | Torrance | California | 90509 | — |
| Hartford Hospital Institute of Living | Hartford | Connecticut | 06106 | — |
| TMS Specialists Chicago | Chicago | Illinois | 60602 | — |
| Sheppard Pratt Health System | Baltimore | Maryland | 21285 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM | Cherry Hill | New Jersey | 08003 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Duke University Brain Stimulation and Neurophysiology Center | Durham | North Carolina | 27710 | — |
| Wake Forest University Medical Center | Winston-Salem | North Carolina | 27157 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic | Pittsburgh | Pennsylvania | 15213 | — |
| Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior | Providence | Rhode Island | 02906 | — |
| MUSC Institute of Psychiatry, Brain Stimulation Lab | Charleston | South Carolina | 29425 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| R/D Clinical Research | Lake Jackson | Texas | 77566 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01370733, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2015 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01370733 live on ClinicalTrials.gov.